Skip to main content

Table 3 Serum and lipid-adjusted concentrations of brominated diphenyl ethers, polychlorinated biphenyls, and persistent organic pesticides, and perfluorinated compounds in polycystic ovary syndrome (PCOS) case-patients and controls

From: Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol a in polycystic ovary syndrome: a case–control study

 

Geometric mean whole weight concentration (pg/g serum)

Lipid-adjusted concentration (ng/g lipid)

Compounds

Case-patients

Controls

Case-patients

Controls

Brominated (Bi-) Diphenyl Ethers

    

2,4,4′-tribromodiphenyl ether (PBDE28)

10.8

9.9

1.9

1.8

2,2′,4,4′-tetrabromodiphenyl ether (PBDE47)

144.5

148.6

24.9

26.5

2,2′,4.4′,5-pentabromodiphenyl ether (PBDE99)

27.5

28.8

4.7

5.1

2,2′,4,4′,6-pentabromodiphenyl ether (PBDE100)

27.8

29.8

4.8

5.3

2,2′,4,4′,5,5′-hexabromobiphenyl (BB153)

3.3

6.0

0.6

1.0a

2,2′,4,4′,5,5′-hexabromodiphenyl (PBDE153)

29.7

34.3

5.1

6.1

Polychlorinated Biphenyls

    

2,2′,4,4′,5-pentaCB (PCB99)

10.8

12.8

1.9

2.3

2,3,3′,4,4′-pentaCB (PCB105)

3.8

3.8

0.7

0.7

2,3′,4,4′,5-pentaCB (PCB118)

15.6

15.6

2.7

2.8

2,2′,3,4′,5,5′-hexaCB (PCB146)

4.2

5.0

0.7

0.9

2,2′,4,4′,5,5′-hexaCB (PCB153)

38.6

47.2

6.7

8.4

2,3,3′,4,4′,5-hexaCB (PCB156)

4.3

5.4

0.7

1.0

2,2′,3,4,4′,5′-hexaCB (PCB138-158)

31.5

35.7

5.4

6.4

2,2′,3,3′,4,4′,5-heptaCB (PCB170)

9.9

12.0

1.7

2.1

2,2′,3,4,4′,5,5′-heptaCB (PCB180)

25.1

29.7

4.3

5.3b

2,2′,3,4,4′,5′,6-heptaCB (PCB183)

3.8

4.4

0.7

0.8

2,2′,3,4′,5,5′,6-heptaCB (PCB187)

7.1

9.2

1.2

1.7

2,2′,3,3′,4,5,6,6′-octaCB (PCB199)

4.0

5.3

0.7

0.9

2,2′,3,3′,4,4′,5,5′-octaCB (PCB 194)

0.7

1.1

0.7

1.1

2,2′,3,3′,4,4′,5′,6-octaCB and 2,2′,3,4,4′,5,5′,6-octaCB (PCB196_203)

4.6

6.2

0.8

1.1

Persistent pesticides

    

Hexachlorobenzene (HCB)

53.9

51.2

9.2

9.1

β-Hexachlorocyclohexane (B-HCCH)

16.0

16.1

4.2

4.4

Oxychlordane

18.6

23.1

3.2

4.1

Trans-Nonachlor

29.6

31.9

5.1

5.7

2,2-Bis(4-chlorophenyl)-1, 1-dichloroethene (PP DDE)

1217.5

1397.2

210.2

248.7

2,2-Bis(4-chlorophenyl-1, 1, 1-trichloroethane (PP DDT)

19.0

18.1

3.3

3.2

Perfluorinated Compounds

μg/L serum

μg/L serum

  

Perfluorooctanoate (PFOA)

4.1

2.3c

  

Perfluorooctane sulfonate (PFOS)

8.2

4.9d

  

Perfluorohexane sulfonate (PFHxS)

1.1

0.7

  

Perfluorononanoate (PFNA)

1.2

0.9

  
  1. ap = 0.02 where controls have higher BB153 levels than case-patients.
  2. bp = 0.04 where controls have higher PCB180 levels than case-patients.
  3. cp = 0.001 where case-patients have higher PFOA levels than controls.
  4. dp = 0.01 where case-patients have higher PFOS levels than controls.